2022-08-01 13510751 2023-07-31 13510751 2022-08-01 2023-07-31 13510751 2022-07-31 13510751 2021-07-14 2022-07-31 13510751 uk-core:WithinOneYear 2022-07-31 13510751 uk-core:WithinOneYear 2023-07-31 13510751 uk-core:AfterOneYear 2022-07-31 13510751 uk-core:AfterOneYear 2023-07-31 13510751 uk-core:ShareCapital 2023-07-31 13510751 uk-core:ShareCapital 2022-07-31 13510751 uk-core:RetainedEarningsAccumulatedLosses 2023-07-31 13510751 uk-core:RetainedEarningsAccumulatedLosses 2022-07-31 13510751 uk-bus:Director1 2022-08-01 2023-07-31 13510751 uk-core:ComputerEquipment 2022-08-01 2023-07-31 iso4217:GBP xbrli:pure 13510751 uk-bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 13510751 uk-bus:FRS102 2022-08-01 2023-07-31 13510751 uk-bus:FilletedAccounts 2022-08-01 2023-07-31 13510751 uk-bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31
McLellan Ferguson Clinical Ltd
Registered Number:13510751
For the year ended 31 July 2023
England and Wales
Unaudited Financial Statements
2
For the year ended 31 July 2023
McLellan Ferguson Clinical Ltd
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
3
Registered Number :
13510751
As at 31 July 2023
McLellan Ferguson Clinical Ltd
Statement of Financial Position
£
£
2022
2023
Notes
Fixed assets
Property, plant and equipment
328
437
2
328
437
Current assets
Trade and other receivables
3,150
6,113
3
13,969
Cash and cash equivalents
11,624
17,737
17,119
Trade and other payables: amounts falling due
within one year
(13,114)
(9,034)
4
4,005
8,703
Net current assets
Total assets less current liabilities
9,031
4,442
Trade and other payables: amounts falling due after
more than one year
(38)
(8,459)
5
572
Net assets
4,404
Capital and reserves
Called up share capital
100
100
Retained earnings
472
4,304
572
4,404
Shareholders' funds
For the year ended 31 July 2023 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company
as at the end of each financial year and of its profit or loss for each financial year in accordance with
the requirements of Section 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been deliver
ed.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
1 of 4
4
Registered Number :
13510751
For the year ended 31 July 2023
McLellan Ferguson Clinical Ltd
Statement of Financial Position Continued
Miss Heather Ferguson Director
These financial statements were approved and authorised for issue by the Board on 02 February 2024 and were signed by:
The notes form part of these financial statements
2 of 4
5
For the year ended 31 July 2023
McLellan Ferguson Clinical Ltd
Notes to the Financial Statements
Statutory Information
McLellan Ferguson Clinical Ltd is a private limited company, limited by shares, domiciled in England
and Wales, registration number 13510751.
Registered address:
1 Park Hill
Gaddesby
Leicester
Leicestershire
LE7 4WH
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of
Financial Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and
Republic of Ireland'' and the Companies Act 2006. The financial statements have been prepared
under the historical costs convention as modified by the revaluation of certain assets.
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
25 Reducing balance
Computer Equipment
2. Property, plant and equipment
Computer
Equipment
£
Cost or
valuation
At 01 August 2022
583
At 31 July 2023
583
Provision for depreciation and impairmen
t
At 01 August 2022
146
Charge for year
109
At 31 July 2023
255
At 31 July 2023
Net book value
328
At 31 July 2022
437
3 of 4
6
For the year ended 31 July 2023
McLellan Ferguson Clinical Ltd
Notes to the Financial Statements Continued
3. Trade and other receivables
2022
2023
£
£
Trade debtors
6,113
3,150
4. Trade and other payables: amounts falling due within one year
2022
2023
£
£
Taxation and social security
9,034
12,976
Other creditors
-
138
9,034
13,114
5. Trade and other payables: amounts falling due after more than one year
2022
2023
£
£
Other creditors
8,459
38
6. Average number of persons employed
During the year the average number of employees was 0 (2022 : 1)
4 of 4